Seres Therapeutics Price to Book Ratio 2013-2021 | MCRB

Historical price to book ratio values for Seres Therapeutics (MCRB) over the last 10 years. The current price to book ratio for Seres Therapeutics as of October 22, 2021 is 5.65.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Seres Therapeutics Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 6.23 5.65
2021-06-30 23.85 $1.10 21.64
2021-03-31 20.59 $1.57 13.12
2020-12-31 24.50 $1.91 12.82
2020-09-30 28.31 $2.06 13.73
2020-06-30 4.76 $-0.87 -5.45
2020-03-31 3.57 $-0.86 -4.15
2019-12-31 3.45 $-0.69 -5.01
2019-09-30 4.01 $-0.46 -8.71
2019-06-30 3.22 $-0.26 -12.53
2019-03-31 6.87 $-1.70 -4.04
2018-12-31 4.52 $-1.17 -3.85
2018-09-30 7.59 $-0.75 -10.14
2018-06-30 8.60 $-0.33 -26.45
2018-03-31 7.34 $0.25 29.74
2017-12-31 10.14 $1.50 6.78
2017-09-30 16.04 $2.11 7.60
2017-06-30 11.30 $2.18 5.19
2017-03-31 11.27 $2.76 4.08
2016-12-31 9.90 $3.29 3.01
2016-09-30 12.29 $3.82 3.22
2016-06-30 29.05 $4.20 6.92
2016-03-31 26.56 $4.84 5.49
2015-12-31 35.09 $5.26 6.68
2015-09-30 29.64 $5.69 5.21
2015-06-30 41.50 $3.12 13.30
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.571B $0.033B
Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76